Meyka AI API is live for developers.Start building.
Advertisement
BillionToOne, Inc.

BillionToOne, Inc. (BLLN) Stock Overview

Explore BillionToOne, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BLLNNASDAQ
HealthcareMedical - Diagnostics & Research
$97.19
$7.40(7.08%)
U.S. Market opens in 53h 12m
Advertisement

BillionToOne, Inc. (BLLN)

Meyka AI Score

Z

Key Financials

Market Cap4.5B
P/E Ratio175.93
EPS (TTM)$0.54
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$80.67
3 Months$47.78
1 Year Target$31.99

BLLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BillionToOne, Inc. (BLLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $31.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 175.93 and a market capitalization of 4.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.08%
5-Day Change
-0.16%
1-Month Change
21.64%
3-Month Change
34.67%
6-Month Change
-12.94%
Year-to-Date (YTD) Change
18.76%
1-Year Change
-10.79%
3-Year Change
-10.79%
5-Year Change
-10.79%
All-Time (Max) Change
-10.79%

Contact Information

(650) 460-2551
1035 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

620 Employees
IPO DateNov 6, 2025
CountryUS
Actively Trading

Frequently Asked Questions